Barnekreft er annerledes

Tidsskrift for den Norske Laegeforening

Volumn 136, Issue 17, 2016, Pages 1464-1466

  Zeller, Bernward ^a   Wesenberg, Finn ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; HUMAN; INFANT; LEUKEMIA; NEOPLASMS; NORWAY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LEUKEMIA; NEOPLASMS; NORWAY;

EID: 84991219272     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.16.0336     Document Type: Article

References (15)

1. Norsk kvalitetsregister for barnekreft. Årsrapport 1985-2014. Oslo: Kreftregisteret, 2015. https://kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/2015/aarsrapport_2015_barnekreft.pdf (9.8.2016).
2. Gatta G, Botta L, Rossi S et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 35-47.
3. Cancer Registry of Norway. Cancer in Norway 2014-Cancer Incidence, mortality, survival and prevalence in Norway. Oslo: Cancer registry of Norway, 2015 https://kreftregisteret.no/Generelt/Publikasjoner/Cancer-in-Norway/Cancer-in-Norway-2014/(9.8.2016).
4. Del Risco Kollerud R, Blaasaas KG, Claussen B. Risk of leukaemia or cancer in the central nervous system among children living in an area with high indoor radon concentrations: results from a cohort study in Norway. Br J Cancer 2014; 111: 1413-20.
5. Pedersen C, Raaschou-Nielsen O, Rod NH et al. Distance from residence to power line and risk of childhood leukemia: a population-based casecontrol study in Denmark. Cancer Causes Control 2014; 25: 171-7.
6. Aydin D, Feychting M, Schüz J et al. Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study. J Natl Cancer Inst 2011; 103: 1264-76.
7. Pakkeforløp for kreft hos barn. Oslo: Helsedirektoratet 2015 https://helsedirektoratet.no/retningslinjer/pakkeforlop-for-kreft-hos-barn (9.8.2016).
8. Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 1948; 238: 787-93.
9. Kolmannskog S, Flaegstad T, Helgestad J et al. Akutt lymfatisk leukemi hos barn i Norge 1992-2000. Tidsskr Nor Lægeforen 2007; 127: 1493-5.
10. Lie SO, Abrahamsson J, Clausen N et al. Longterm results in children with AML: NOPHO-AML Study Group-report of three consecutive trials. Leukemia 2005; 19: 2090-100.
11. Gustafsson G, Schmiegelow K, Forestier E et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000; 14: 2267-75.
12. Oeffinger KC, Mertens AC, Sklar CA et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-82.
13. Ruud E, Kanellopoulos A, Zeller B et al. Senfølger etter akutt lymfatisk leukemi-hva vet pasientene? Tidsskr Nor Legeforen 2012; 132: 2052-5.
14. Helgestad J, Monge OR, Ulvestad E et al. Kreft hos barn-gode resultater kan bli enda bedre. Tidsskr Nor Lægeforen 2006; 126: 926-9.
15. Gatta G, Corazziari I, Magnani C et al. Childhood cancer survival in Europe. Ann Oncol 2003; 14 (suppl 5): v119-27.